Lakefront Biotherapeutics NV (LKFT34)
Market Open
13 Oct, 07:55 PM
B3 B3 Primary R$
7. 45
-0.03
-0.4011%
R$
9.7B Market Cap
- P/E Ratio
- Div Yield
1 Volume
- Eps
R$ 7.48
Previous Close Want to track LKFT34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lakefront Biotherapeutics NV (LKFT34) Statistics
Valuation metrics
Market Cap 9.7B
Enterprise value 45.24B
Trailing P/E (ttm) 2.71
Forward P/E -
PEG ratio -
Price/Sales (ttm) 10
Price/Book (mrq) 0.52
Enterprise Value/Revenue 7.77
Enterprise Value/EBITDA 13.52
Overview
Shares outstanding 65.66M
Float 474.38M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6
Average volume (90 days) 140
Price summary
52-Week low 5.97
52-Week high 9.34
Beta 0.12
50-Day moving average 7.14
200-Day moving average 7.75
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2026
Profitability
Profit margin 0.6%
Operating margin -3.59%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.2%
Income Statement
Revenue (ttm) 5.82B
Revenue per share (ttm) 0.75
Quarterly revenue growth (yoy) -0.81%
Gross profit (ttm) 3.94B
EBITDA 604.67M
Net income to common (ttm) 3.49B
Diluted EPS (ttm) 2.79
Quarterly earnings growth (yoy) -0.81%
Balance Sheet
Total cash (mrq) 13.17B
Total cash per share (mrq) 1.71
Total debt (mrq) 37.41M
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 32.84%
Book value per share (mrq) 14.59
Cash Flow
Cash flow statement -1.33B
Levered free cash flow (LFCF) 812.59M
2026 © Marketlog. All Rights Reserved.
